FY2024 Earnings Forecast for BioSyent Issued By Bloom Burton

BioSyent Inc. (CVE:RX) – Stock analysts at Bloom Burton raised their FY2024 earnings per share estimates for BioSyent in a report released on Thursday, November 21st. Bloom Burton analyst D. Martin now forecasts that the company will post earnings per share of $0.63 for the year, up from their previous forecast of $0.59. The consensus estimate for BioSyent’s current full-year earnings is $0.69 per share. Bloom Burton also issued estimates for BioSyent’s FY2025 earnings at $0.80 EPS and FY2026 earnings at $0.91 EPS.

BioSyent (CVE:RX) last posted its quarterly earnings results on Monday, August 26th. The company reported C$0.13 earnings per share for the quarter, meeting analysts’ consensus estimates of C$0.13. The company had revenue of C$8.95 million for the quarter, compared to the consensus estimate of C$8.80 million. BioSyent had a net margin of 21.14% and a return on equity of 20.88%.

BioSyent Price Performance

RX stock opened at C$11.25 on Monday. The stock has a market cap of C$130.39 million, a price-to-earnings ratio of 18.75 and a beta of 0.93. The company has a debt-to-equity ratio of 3.19, a current ratio of 6.13 and a quick ratio of 6.91. The company has a 50 day simple moving average of C$11.05 and a 200 day simple moving average of C$10.27. BioSyent has a 1 year low of C$8.20 and a 1 year high of C$11.49.

Insider Transactions at BioSyent

In related news, Director Seyed Ahmad Ashrafi sold 2,320 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of C$10.95, for a total value of C$25,404.00. Company insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.